Annual Operating Expenses
$16.36 M
+$1.08 M+7.05%
December 1, 2023
Summary
- As of March 10, 2025, TNFA annual total operating expenses is $16.36 million, with the most recent change of +$1.08 million (+7.05%) on December 1, 2023.
- During the last 3 years, TNFA annual operating expenses has risen by +$8.06 million (+97.20%).
- TNFA annual operating expenses is now -41.99% below its all-time high of $28.20 million, reached on December 1, 2021.
Performance
TNFA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.83 M
-$35.40 K-1.90%
September 1, 2024
Summary
- As of March 10, 2025, TNFA quarterly total operating expenses is $1.83 million, with the most recent change of -$35.40 thousand (-1.90%) on September 1, 2024.
- Over the past year, TNFA quarterly operating expenses has stayed the same.
- TNFA quarterly operating expenses is now -89.99% below its all-time high of $18.24 million, reached on June 1, 2021.
Performance
TNFA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TNFA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | 0.0% |
| 3 y3 years | +97.2% | -50.8% |
| 5 y5 years | +97.2% | -24.8% |
TNFA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.0% | +7.0% | -68.4% | at low |
| 5 y | 5-year | -42.0% | +97.2% | -90.0% | at low |
| alltime | all time | -42.0% | +97.2% | -90.0% | at low |
TNF Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.83 M(-1.9%) |
| Jun 2024 | - | $1.86 M(-33.2%) |
| Mar 2024 | - | $2.78 M(-43.3%) |
| Dec 2023 | $16.36 M(+7.0%) | $4.91 M(+27.7%) |
| Sep 2023 | - | $3.84 M(-33.5%) |
| Jun 2023 | - | $5.78 M(+216.4%) |
| Mar 2023 | - | $1.83 M(-52.0%) |
| Dec 2022 | $15.28 M | $3.81 M(+2.6%) |
| Sep 2022 | - | $3.71 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.64 M(-11.6%) |
| Mar 2022 | - | $4.12 M(+31.9%) |
| Dec 2021 | $28.20 M(+239.9%) | $3.13 M(-29.1%) |
| Sep 2021 | - | $4.41 M(-75.8%) |
| Jun 2021 | - | $18.24 M(+650.8%) |
| Mar 2021 | - | $2.43 M(-47.6%) |
| Dec 2020 | $8.30 M | $4.64 M(+138.6%) |
| Sep 2020 | - | $1.94 M(-45.1%) |
| Mar 2020 | - | $3.54 M |
FAQ
- What is TNF Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual operating expenses year-on-year change?
- What is TNF Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly operating expenses year-on-year change?
What is TNF Pharmaceuticals annual total operating expenses?
The current annual operating expenses of TNFA is $16.36 M
What is the all time high annual operating expenses for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual total operating expenses is $28.20 M
What is TNF Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, TNFA annual total operating expenses has changed by +$1.08 M (+7.05%)
What is TNF Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of TNFA is $1.83 M
What is the all time high quarterly operating expenses for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly total operating expenses is $18.24 M
What is TNF Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, TNFA quarterly total operating expenses has changed by $0.00 (0.00%)